Conan MedTech
Real-time concussion detection
Conan MedTech operates in diagnostics based in East Coast, Northeastern US, founded in 2020.
Profile
Conan MedTech is producing a rapid POC diagnostic test for concussions that can be performed on the sidelines. The company’s lateral flow device uses highly specific monoclonal antibodies to recognize neuronal biomarkers, which show up in saliva immediately after concussions.
Conan MedTech is positioned in diagnostics, a segment that rewards a clear, focused offering.
The company is recorded as being based in East Coast, Northeastern US.
The company is listed at the Seed stage of development.
The company reports a headcount in the 2-10 range.
Public records show total funding of about $668K.
| Sector | Diagnostics |
|---|---|
| Headquarters | East Coast, Northeastern US |
| Country | United States |
| Founded | 2020 |
| Employees | 2-10 |
| Stage | seed |
| Total funding | $668,000 |
Website: www.conanmedtech.com
Sign in to view the contact information we hold for Conan MedTech.
Create a free account
Create a free account